This observation indicates that IL8 may be used as a biomarker to differentiate acute as well as subacute inflammatory demyelinating neuropathies from chronic ones, but this needs to be verified in a larger cohort. The gene discussed is CXCL8; the disease is Guillain-Barre syndrome, familial.